← Back to Search

Patient: Scheduled for mammogram for Breast Cancer

N/A
Waitlist Available
Led By Whitney Hensing, M.D., M.S.
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Female
African American
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through mammogram appointment (estimated to be 6 months)
Awards & highlights

Study Summary

Eliminating racial disparities in breast cancer is a top public health priority. African American (AA) women often present with more advanced and aggressive disease at the time of diagnosis and are more likely to die from breast cancer than any other racial/ethnic group in the United States. Mammogram screening significantly reduces breast cancer mortality by diagnosing cancer at an earlier stage where treatments are more effective. While some AA women do not schedule screening mammograms as recommended by current guidelines, others do not show up for their exams after scheduling them (no-shows). No-shows to cancer screening appointments impose an enormous strain on our limited healthcare resources with negative impact on other patients who could have secured earlier appointments, loss of revenue for hospitals or clinics serving underserved populations and delays in diagnoses and treatment for those who do not have screening. The investigators identified a high no-show rate for screening mammograms at our hospital. AA women were almost three times more likely to no-show for their mammograms compared to White women. Patient's social networks plan an important role in health promotion. In this study, we will pilot an intervention involving patient's social contacts (family, friends, neighbors, etc.) as healthcare facilitators to improve appointment attendance. The investigators seek to determine whether this intervention is feasible and acceptable to patients and whether this intervention will improve attendance rates for screening mammograms among AA women at our institution. If effective, the use of a patient's social contact person as a healthcare facilitator (similar to a patient navigator) would be a readily available and inexpensive resource for other institutions to implement.

Eligible Conditions
  • Breast Cancer

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through mammogram appointment (estimated to be 6 months)
This trial's timeline: 3 weeks for screening, Varies for treatment, and through mammogram appointment (estimated to be 6 months) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility of recruiting patients' social contacts to serve as healthcare facilitators as measured by number of participants enrolled to the study with a social contact that agrees to participate
Secondary outcome measures
Describe demographic characteristics of the social contacts and any associations with patient appointment attendance
Rate of mammography attendance
Using a structured survey interview, determine the percentage of patients and their social contacts who respond positively (agree or strongly agree) that the intervention helped them keep their scheduled screening mammogram appointment

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Patient: Scheduled for mammogramExperimental Treatment1 Intervention
Will be asked to choose 2 social contacts (adult family member or friend identified by the participant as someone who could be engaged by the research team to encourage the participant to attend her mammogram appointment) Will receive reminder(s) from social contact about the screening mammogram appointment Will receive reminder from Breast Health Center about screening mammogram appointment Will be contacted to provide experience with the study
Group II: Social Contact of PatientActive Control1 Intervention
Facilitate enrolled patient to complete the screening mammogram. Will receive information about screening mammograms and resources available at the Breast Imaging Center. Will be contacted approximately 3 days prior to the patient's mammogram appointment. Will be contacted to provide experience with the study
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Social Contact Reminder
2022
N/A
~160

Find a Location

Who is running the clinical trial?

Washington University School of MedicineLead Sponsor
1,928 Previous Clinical Trials
2,296,932 Total Patients Enrolled
46 Trials studying Breast Cancer
5,012 Patients Enrolled for Breast Cancer
American Society of Clinical OncologyOTHER
33 Previous Clinical Trials
147,397 Total Patients Enrolled
7 Trials studying Breast Cancer
814 Patients Enrolled for Breast Cancer
Whitney Hensing, M.D., M.S.Principal InvestigatorWashington University School of Medicine

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~52 spots leftby Mar 2025